A Phase 1 Study of PS-341 in Combination With Docetaxel in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs Bortezomib (Primary) ; Docetaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 23 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 25 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2005 New trial record.